PHK
TXMD icon

Point72 Hong Kong’s TherapeuticsMD TXMD Stock Holding History

Point72 Hong Kong’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,351
Closed -$93K – 2430
2022
Q2 		$93K Buy
9,351
+9,124
+4,019% +$87.1K ﹤0.01% 1201
2022
Q1 		$4K Sell
227
-2,243
-91% -$35.3K ﹤0.01% 1697
2021
Q4 		$44K Buy
2,470
+1,737
+237% +$52.1K ﹤0.01% 1377
2021
Q3 		$27K Buy
+733
New +$32.5K ﹤0.01% 1643
2021
Q1 		– Sell
-50
Closed -$3K – 2223
2020
Q4 		$3K Buy
+50
New +$3.41K ﹤0.01% 1628
2020
Q1 		– Sell
-30
Closed -$4K – 1364
2019
Q4 		$4K Sell
30
-104
-78% -$15K ﹤0.01% 1057
2019
Q3 		$24K Buy
+134
New +$18.9K 0.01% 688

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Point72 Hong Kong's TXMD Position: Q3 2022 in Review

Point72 Hong Kong sold out of TherapeuticsMD (TXMD) in Q3 2022, closing a stake of 9,351 shares — an estimated $93K sold.

Point72 Hong Kong first reported a position in TXMD in Q3 2019 and held it in 7 quarters. The position peaked at $93K in Q2 2022. 43 funds tracked by Wall St. Rank hold TXMD as of Q3 2022.

  • Point72 Hong Kong reported no remaining TherapeuticsMD position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 9,351 TherapeuticsMD shares in Q3 2022, an estimated $93K.
  • Point72 Hong Kong first reported a position in TherapeuticsMD in Q3 2019 and held it in 7 quarters.
  • Point72 Hong Kong's TherapeuticsMD position peaked at $93K in Q2 2022.
  • 43 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.